Controlled extraction studies aim to obtain extensive analytical data for drug containers and medical devices, and therefore recognize compounds and materials that may generate safety and performance concerns. It is, however, a challenge to sift and interpret data to find extractable signals from different instruments, especially when using a variety of hyphenated chromatography–mass spectrometry analyses. Therefore informatics technologies and software automation of workflows are becoming key strategic considerations for identification, elucidation, and characterization of extractables and leachables (E&L).
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
17th International Conference on Neurology and Neuroscience
IntelliXtract 2.0: Simplified Intelligent Component Extraction and Detection
Anne Marie Smith, Richard Lee, Vitaly Lashin, Andrey Paramonov
A new biotransformation prediction engine integrated into a metabolite identification solution.
Richard Lee, Rytis Kubilius, Vitaly Lashin, Alexandre Sakarov
A new method for analyzing MSe/All Ions Fragmentation in xenobiotic metabolism studies
Richard Lee, Vitaly Lashin, Alexandre Sakarov, Andrey Paramonov
www.thebraindomain.org: Science Writing for Public Engagement
Bartley, O.; Rienecker, K.; Stickland, R.; Pass, R.; Bunga, A.; Cross, E.; & Fagg, J.